Deferasirox
Deferasirox (marketed as Exjade, Desirox, Defrijet, Desifer…) is an iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the USA for this purpose.
| Catalog Number | 10-101-115 |
| Alternative Name(s) | 4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid, CGP-72670, ICL-670, ICL-670A |
| Research Area | For the management or treatment of transfusional iron overload. |
| Molecular Formula | C21H15N3O4 |
| CAS# | 201530-41-8 |
| Purity | >98% |
| Inchi | InChI=1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28) |
| Inchi Key | BOFQWVMAQOTZIW-UHFFFAOYSA-N |
| SMILES | C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1 |
| Size | Inquiry |
| Supplier Page | https://www.creative-peptides.com/product/deferasirox-item-10-101-115-36.html |